Difficulty: Medium
Average Score: 74%
Practice
A patient presented with progressive cognitive decline, an emerging personality disorder, and chorea. He was diagnosed with a neurodegenerative disorder, and his chorea was treated with phenothiazines. A CT scan showed atrophy of the head of the caudate nucleus. Which neurotransmitter is primarily involved in this disorder?
Correct answer
C
Rationale
The correct answer is C) GABA. In the context of the presented case, the patient's symptoms of progressive cognitive decline, personality disorder, chorea, and atrophy of the caudate nucleus point towards Huntington's disease, a neurodegenerative disorder characterized by a reduction in GABAergic inhibition. GABA (gamma-aminobutyric acid) is the major inhibitory neurotransmitter in the brain and is particularly important in regulating movement and cognitive functions. In Huntington's disease, there is a loss of GABAergic neurons in the caudate nucleus, leading to the symptoms described.
Option A) 5-hydroxytryptamine (serotonin) is not primarily involved in this disorder. While serotonin dysfunction can contribute to mood disorders, it is not the main neurotransmitter affected in Huntington's disease.
Option B) Acetylcholine is not primarily involved in this disorder. Acetylcholine plays a role in motor control and cognitive function, but its dysfunction is not the primary cause of symptoms seen in Huntington's disease.
Option D) Norepinephrine is not primarily involved in this disorder. Norepinephrine is involved in the body's stress response and mood regulation, but it is not the neurotransmitter primarily affected in Huntington's disease.
Understanding the role of neurotransmitters in neurodegenerative disorders is crucial for healthcare professionals to accurately diagnose and manage patients with such conditions. This question provides a valuable learning opportunity to reinforce the relationship between neurotransmitter dysfunction and specific clinical manifestations seen in neurodegenerative diseases.
Option A) 5-hydroxytryptamine (serotonin) is not primarily involved in this disorder. While serotonin dysfunction can contribute to mood disorders, it is not the main neurotransmitter affected in Huntington's disease.
Option B) Acetylcholine is not primarily involved in this disorder. Acetylcholine plays a role in motor control and cognitive function, but its dysfunction is not the primary cause of symptoms seen in Huntington's disease.
Option D) Norepinephrine is not primarily involved in this disorder. Norepinephrine is involved in the body's stress response and mood regulation, but it is not the neurotransmitter primarily affected in Huntington's disease.
Understanding the role of neurotransmitters in neurodegenerative disorders is crucial for healthcare professionals to accurately diagnose and manage patients with such conditions. This question provides a valuable learning opportunity to reinforce the relationship between neurotransmitter dysfunction and specific clinical manifestations seen in neurodegenerative diseases.